To define the prognostic role of multiple epidemiological, clinical, and biological factors for the development of multiple malignancies (MM) in patients with head and neck cancer (HNC).
Study Design
Historical cohort study. p53 gene status, microsatellite instability (MSI) of the index tumor, and inherited chromosome fragility (CF) were studied.
Setting
Ninety-six consecutive patients affected by primary HNC, between January 1987 and October 1991, who were eligible for curative radiation therapy were followed up.
Subjects and Methods
p53 gene status, MSI, and CF in 96 curative radiotherapy-treated patients were correlated with the risk for MM.
Results
Multiple malignancies occurred in 28.9%. Microsatellite instability (P = 0.05), CF (P < 0.01), and smoking after treatment of the index tumor (P = 0.02) were correlated with an increased risk of MM.
Conclusion
Genetic susceptibility may play a central role for MM development in patients with HNC.
SpitzMRHoqueATriznaZ. Mutagen sensitivity as a risk factor for second malignant tumors following malignancies of the upper aerodigestive tract. J Natl Cancer Inst. 1994;16(86):1681-1684.
2.
CloosJLeemansCRvan der SterreMLKuikDJSnowGBBraakhuisBJ. Mutagen sensitivity as a biomarker for second primary tumors after head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2000;9:713-717.
3.
GalloOBianchiSGiovannucci-UzzielliML. p53 oncoprotein overexpression correlates with mutagen-induced chromosome fragility in head and neck cancer patients with multiple malignancies. Br J Cancer. 1995;71:1008-1012.
4.
FoulkesWDBrunetJSSiehWBlackMJShenoudaGNarodSA. Familial risks of squamous cell carcinoma of the head and neck: retrospective case-control study. BMJ. 1996;313:716-721.
5.
HoriiAHanHJShimadaM. Frequent replication errors at microsatellite loci in tumors of patients with multiple primary cancers. Cancer Res. 1994;54:3373-3375.
6.
GalloOChiarelliIBoddiVBoccioliniCBruschiniLPorfirioB. Cumulative prognostic value of p53 mutations and bcl-2 protein expression in head-and-neck cancer treated by radiotherapy. Int J Cancer. 1999;84:573-579.
7.
DeganelloAFranchiASardiIPignataroLLeemansCRGalloO. Genetic alterations between primary head and neck squamous cell carcinoma and recurrence after radiotherapy: recurrence, genetically related cancer, or second primary?Cancer. 2010;116:1291-1297.
8.
WangLWuQQiuP. Analyses of p53 target genes in the human genome by bioinformatic and microarray approaches. J Biol Chem. 2001;276:43604-43610.
9.
LeungWKKimJJKimJGGrahamDYSepulvedaAR. Microsatellite instability in gastric intestinal metaplasia in patients with and without gastric cancer. Am J Pathol. 2000;156:537-543.
10.
GalloOSardiIPepeG. Multiple primary tumors of the upper aerodigestive tract: is there a role for constitutional mutations in the p53 gene?Int J Cancer. 1999;82:180-186.
ShinDMLeeJSLippmanSM. p53 expressions: predicting recurrence and second primary tumors in head and neck squamous cell carcinoma. J Natl Cancer Inst. 1996;88:519-529.
13.
SardiIFranchiAFerrieroG. Prediction of recurrence by microsatellite analysis in head and neck cancer. Genes Chromosomes Cancer. 2000;29:201-206.
14.
HaPKCalifanoJA. The molecular biology of mucosal field cancerization of the head and neck. Crit Rev Oral Biol Med. 2003;14:363-369.
15.
WangLEHuZSturgisEM. Reduced DNA repair capacity for removing tobacco carcinogen–induced DNA adducts contributes to risk of head and neck cancer but not tumor characteristics. Clin Cancer Res. 2010;16:764-774.
16.
WangLEXiongPZhaoHSpitzMRSturgisEMWeiQ. Chromosome instability and risk of squamous cell carcinomas of head and neck. Cancer Res. 2008;68:4479-4485.
17.
CalifanoJWestraWHMeiningerGCorioRKochWMSidranskyD. Genetic progression and clonal relationship of recurrent premalignant head and neck lesions. Clin Cancer Res. 2000;6:347-352.
18.
RichardsRI. Fragile and unstable chromosomes in cancer: causes and consequences. Trends Genet. 2001;17:339-345.
19.
NunnJNaginiSRiskJM. Allelic imbalance at the DNA mismatch repair loci, hMSH2, hMLH1, hPMS1, hPMS2 and hMSH3, in squamous cell carcinoma of the head and neck. Oral Oncol. 2003;39:115-129.
20.
GalTJHuangWYChenCHayesRBSchwartzSM. DNA repair gene polymorphisms and risk of second primary neoplasms and mortality in oral cancer patients. Laryngoscope. 2005;115:2221-2231.
21.
DemokanSSuogluYDemirDGozelerMDalayN. Microsatellite instability and methylation of the DNA mismatch repair genes in head and neck cancer. Ann Oncol. 2006;17:995-999.
22.
SnowGB. Follow-up in patients treated for head and neck cancer: how frequent, how thorough and for how long?Eur J Cancer. 1992:28:315-316.
